Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Sunday, December 6, 2009, 5:06PM ET - U.S. Markets Closed. Dow Up 0.22% Nasdaq Up 0.98%
IVAX Diagnostics Inc. (IVD)On Dec 4: 0.53  Down 0.07 (11.67%)  
MORE ON IVD
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
IVAX Diagnostics Inc.
2140 North Miami Avenue
Miami, FL 33127
United States - Map
Phone: 305-324-2300
Fax: 305-575-6055
Web Site: http://www.ivaxdiagnostics.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Instruments & Supplies
Full Time Employees:106

BUSINESS SUMMARY 
IVAX Diagnostics, Inc., through its subsidiaries, engages in the development, manufacture, and marketing of diagnostic test kits. Its kits are used to aid in the detection of disease markers primarily in the areas of autoimmune and infectious diseases. The company’s tests are based on enzyme linked immunosorbent assay (ELISA) technology, a clinical testing methodology. It also designs and manufactures laboratory instruments, including Mago Plus and Aptus systems that perform the tests in an automated mode, as well as autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers to produce autoimmune diagnostic kits. IVAX Diagnostics sells its products to hospitals, reference laboratories, clinical and research laboratories, and pharmaceutical and biotechnology companies, as well as to other commercial companies that manufacture diagnostic products primarily in the United States and Italy. The company was founded in 1980 and is headquartered in Miami, Florida.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on IVAX Diagnostics Inc.


    CORPORATE GOVERNANCE 
    IVAX Diagnostics Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Dec-09 is better than 22.8% of CGQ Universe companies and 12% of Health Care Equipment & Services companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Mark Deutsch , 48
    Chief Financial Officer, Principal Accounting Officer, VP of Fin., Sec. and VP of Fin. - Diamedix
    N/A N/A
    Mr. Kevin D. Clark , 46
    Chief Operating Officer
    $ 373.00KN/A
    Dr. Charles R. Struby Ph.D., 59
    Chief Exec. Officer and Pres
    N/A N/A
    Mr. Ray Earl ,
    VP of Sales - Diamedix Corp
    N/A N/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis